Impact of Albumin-to-Creatinine Ratio Point-of-Care Testing on the Diagnosis and Management of Diabetic Kidney Disease
Authors' conclusion
The implementation of ACR POCT may positively affect DKD diagnosis and subsequently allow better management of patients with diabetes.
Study context
- Population
- Patients with diabetes (T1D n = 236; T2D n = 463; other forms n = 18) assessed with albumin-to-creatinine ratio (ACR) point-of-care testing (POCT), three centers
- Participants
- 717 patients
- Outcome
- Effect of ACR POCT use on DKD diagnosis and treatment management for glycemic control and blood pressure
Methodological detailsmulticentre (three centers)
- Multicentre (three centers)
Main finding
As reported in the abstract
- Confirmed/suspected DKD diagnosis (all participants)
- 39.1%
- Newly diagnosed with DKD based on actual ACR POCT values
- 8.6%
- Suspected DKD based on actual ACR POCT values
- 9.9%
- Treatment modification among confirmed/suspected DKD (n = 280)
- 46.1%
- GLP-1 RA initiation among confirmed/suspected DKD
- 11.1%
- SGLT2i initiation among confirmed/suspected DKD
- 8.9%
Observational data: associations, not effects.
Further findings
Physician questionnaire on ACR POCT use (n = 8 physicians)
- Physicians using it to examine patients with diabetes with or without hypertension
- 100%
- Physicians considering it very important for patients with diabetes
- 75%
Original publication
Impact of Albumin-to-Creatinine Ratio Point-of-Care Testing on the Diagnosis and Management of Diabetic Kidney Disease. J Diabetes Sci Technol. Published 28 October 2021. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →